Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,731.8 | 131.88 | 4,15,468.84 | 1,181.05 | 0.78 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,552 | 78.73 | 1,73,905.81 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,482.4 | 24.3 | 1,19,696.35 | 1,485.4 | 1.08 | 4,254.47 | 397.44 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,289 | 61.01 | 1,11,286.02 | 474 | 0.97 | 2,385 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,531.4 | 54.04 | 1,04,508.2 | 416.38 | 0 | 2,396.57 | 334.17 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
